LEADER 3—Lipase and Amylase Activity in Subjects With Type 2 Diabetes: Baseline Data From Over 9000 Subjects in the LEADER Trial

OBJECTIVES: This report from the LEADER (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results) trial describes baseline lipase and amylase activity in type 2 diabetic subjects without acute pancreatitis symptoms before randomization to the glucagonlike peptide anal...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Steinberg, William M., Nauck, Michael A., Zinman, Bernard, Daniels, Gilbert H., Bergenstal, Richard M., Mann, Johannes F.E., Steen Ravn, Lasse, Moses, Alan C., Stockner, Mette, Baeres, Florian M.M., Marso, Steven P., Buse, John B.
Формат: Artigo
Язык:Inglês
Опубликовано: Lippincott Williams & Wilkins 2014
Предметы:
Original Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4206347/
https://ncbi.nlm.nih.gov/pubmed/25275271
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MPA.0000000000000229
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы